secwatch.observer — SEC 8-K summary
======================================

Issuer:     Janux Therapeutics, Inc. (JANX)
CIK:        0001817713
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0000950170-23-011433
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Peter Thompson to not stand for re-election at Janux 2023 annual meeting
--------------------------------------------------------------------------------

- Peter Thompson, M.D., informed Janux he will not stand for re-election to the Board at the 2023 annual meeting due to competing commitments.
- Dr. Thompson's decision is not the result of any disagreement with the Company on operations, policies, or practices.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817713/000095017023011433/0000950170-23-011433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817713/000095017023011433/janx-20230327.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-011433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer